EFFECT OF ARFORMOTEROL TWICE DAILY, TIOTROPIUM ONCE DAILY, AND THEIR COMBINATION IN SUBJECTS WITH COPD
Chest(2008)
Abstract
PURPOSE: Previous studies in subjects with COPD suggest that combined therapy with inhaled β2-agonist and anticholinergics provide increased bronchodilation compared with monotherapies. This was a 2-week, multi-center, randomized, parallel group study designed to evaluate the efficacy and safety of concomitant treatment with nebulized arformoterol (the R,R-isomer of formoterol) and tiotropium DPI.
MoreTranslated text
Key words
COPD,Aerosol Therapy,Treatment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined